{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:10:52Z","timestamp":1779336652911,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.humpath.2010.10.012","type":"journal-article","created":{"date-parts":[[2011,2,12]],"date-time":"2011-02-12T10:29:00Z","timestamp":1297506540000},"page":"983-990","source":"Crossref","is-referenced-by-count":25,"title":["Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancer"],"prefix":"10.1016","volume":"42","author":[{"given":"Coya","family":"Tapia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inti","family":"Zlobec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ergin","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"G\u00fcth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Bubendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suwon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2010.10.012_bb0005","first-page":"2373","article-title":"p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity","volume":"63","author":"Shiseki","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2010.10.012_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.febslet.2004.06.010","article-title":"ING4 induces G2\/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells","volume":"570","author":"Zhang","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.humpath.2010.10.012_bb0015","doi-asserted-by":"crossref","first-page":"16251","DOI":"10.1073\/pnas.0407158101","article-title":"A screen for genes that suppress loss of contact inhibition: identification of ING4 as a candidate tumor suppressor gene in human cancer","volume":"101","author":"Kim","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2010.10.012_bb0020","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature02329","article-title":"The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis","volume":"428","author":"Garkavtsev","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2010.10.012_bb0025","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1158\/0008-5472.CAN-06-3870","article-title":"Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1","volume":"67","author":"Shen","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2010.10.012_bb0030","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1073\/pnas.0502716102","article-title":"The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF)","volume":"102","author":"Ozer","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2010.10.012_bb0035","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1182\/blood-2007-02-074617","article-title":"The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angiogenesis","volume":"110","author":"Colla","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2010.10.012_bb0040","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1182\/blood.V86.10.3869.bloodjournal86103869","article-title":"Loss of heterozygosity in the chromosomal region 12p12-13 is very common in childhood acute lymphoblastic leukemia and permits the precise localization of a tumor-suppressor gene distinct from p27KIP1","volume":"86","author":"Cav\u00e9","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2010.10.012_bb0045","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/bjc.1997.214","article-title":"Ovarian cancer has frequent loss of heterozygosity at chromosome 12p12.3-13.1 (region of TEL and Kip1 loci) and chromosome 12q23-ter: evidence for two new tumour-suppressor genes","volume":"75","author":"Hatta","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2010.10.012_bb0050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/pros.10131","article-title":"Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer","volume":"53","author":"Kawana","year":"2002","journal-title":"Prostate"},{"key":"10.1016\/j.humpath.2010.10.012_bb0055","first-page":"356","article-title":"Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas","author":"Gunduz","year":"2005","journal-title":"Gene"},{"key":"10.1016\/j.humpath.2010.10.012_bb0060","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/carcin\/bgn086","article-title":"Role of ING4 in human melanoma cell migration, invasion and patient survival","volume":"29","author":"Li","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.humpath.2010.10.012_bb0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/path.2571","article-title":"Reduced expression and novel splice variants of ING4 in human gastric adenocarcinoma","volume":"219","author":"Li","year":"2009","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2010.10.012_bb0070","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1158\/1055-9965.EPI-08-0575","article-title":"Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma","volume":"18","author":"Fang","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.humpath.2010.10.012_bb0075","doi-asserted-by":"crossref","first-page":"6632","DOI":"10.1128\/MCB.00697-08","article-title":"The ING4 tumor suppressor attenuates NF-kappaB activity at the promoters of target genes","volume":"28","author":"Nozell","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.humpath.2010.10.012_bb0080","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/jcp.2006.038281","article-title":"HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer","volume":"60","author":"Al-Kuraya","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2010.10.012_bb0085","first-page":"1107","article-title":"HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil","volume":"8","author":"Di Leo","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2010.10.012_bb0090","doi-asserted-by":"crossref","first-page":"7483","DOI":"10.1200\/JCO.2005.11.007","article-title":"Retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative Group","volume":"23","author":"Knoop","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2010.10.012_bb0095","first-page":"1551","article-title":"HER2 analysis in breast cancer: reduced immunoreactivity in FISH non-informative cancer biopsies","volume":"25","author":"Tapia","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1016\/j.humpath.2010.10.012_bb0100","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2010.10.012_bb0105","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"S\u00f8rlie","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2010.10.012_bb0110","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/415530a","article-title":"Gene expression profiling predicts clinical outcome of breast cancer","volume":"415","author":"van 't Veer","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2010.10.012_bb0115","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1200\/JCO.2007.14.4287","article-title":"Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy","volume":"26","author":"Nguyen","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2010.10.012_bb0120","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","article-title":"Repeated observation of breast tumor subtypes in independent gene expression data sets","volume":"100","author":"Sorlie","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2010.10.012_bb0125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3816\/CBC.2004.n.011","article-title":"HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues","volume":"5","author":"Owens","year":"2004","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.humpath.2010.10.012_bb0130","first-page":"4785","article-title":"Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene","author":"Slamon","year":"1987","journal-title":"235"},{"key":"10.1016\/j.humpath.2010.10.012_bb0135","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1200\/JCO.20.3.719","article-title":"Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer","volume":"20","author":"Vogel","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2010.10.012_bb0140","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1038\/sj.onc.1210379","article-title":"Trastuzumab: triumphs and tribulations","volume":"26","author":"Nahta","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2010.10.012_bb0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molcel.2005.12.007","article-title":"ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation","volume":"21","author":"Doyon","year":"2006","journal-title":"Mol Cell"},{"key":"10.1016\/j.humpath.2010.10.012_bb0150","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.molcel.2008.12.016","article-title":"ING4 mediates crosstalk between histone H3 K4 trimethylation and H3 acetylation to attenuate cellular transformation","volume":"33","author":"Hung","year":"2009","journal-title":"Mol Cell"},{"key":"10.1016\/j.humpath.2010.10.012_bb0155","doi-asserted-by":"crossref","first-page":"15956","DOI":"10.1074\/jbc.M710020200","article-title":"Molecular basis of histone H3K4me3 recognition by ING4","volume":"283","author":"Palacios","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.humpath.2010.10.012_bb0160","doi-asserted-by":"crossref","first-page":"8027","DOI":"10.1074\/jbc.275.11.8027","article-title":"HER-2\/neu blocks tumor necrosis factor\u2013induced apoptosis via the Akt\/NF-kappaB pathway","volume":"275","author":"Zhou","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.humpath.2010.10.012_bb0165","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/sj.onc.1204257","article-title":"Her-2\/neu overexpression induces NF-kappaB via a PI3-kinase\/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN","volume":"20","author":"Pianetti","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2010.10.012_bb0170","doi-asserted-by":"crossref","first-page":"10137","DOI":"10.1073\/pnas.0403621101","article-title":"NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis","volume":"101","author":"Biswas","year":"2004","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817710004041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817710004041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T14:06:31Z","timestamp":1592316391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817710004041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0046817710004041"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2010.10.012","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}